Digital Health Transformers Ep 14: Joshua Liu, CEO, SeamlessMD | Remote Patient Monitoring 2.0

Поділитися
Вставка
  • Опубліковано 28 вер 2024
  • Welcome to the Digital Health Transformers podcast series, where we explore the dynamic world of healthcare innovation. In this episode, our host, Nicole Guevara sits down with Joshua Liu, the co-founder and CEO of SeamlessMD, to discuss his journey in transforming the healthcare landscape.
    Joshua, a former physician turned visionary entrepreneur, shares his insights on digitizing patient care journeys and leveraging technology to improve healthcare outcomes. As a strong advocate for digital health, Joshua discusses the challenges he faced in transitioning from clinical to non-clinical roles and the importance of engaging patients in their healthcare journey.
    They delve into the evolution of remote patient monitoring (RPM) from traditional device-based solutions (RPM 1.0) to device-less solutions (RPM 2.0), highlighting the role of technology in improving patient engagement and outcomes. Joshua explains how device-less solutions leverage existing technologies to capture patient data accurately and reliably, empowering patients to report symptoms in real-time.
    Join us as we explore the future of healthcare innovation and the transformative potential of RPM 2.0. Special thanks to our guest, Joshua Liu, and to OSP for bringing you this podcast. Stay tuned for more insightful conversations on healthcare innovation. Don't forget to like, share, and subscribe for the latest updates.
    Revolutionize your healthcare business with our transformative health technologies. Visit us at
    www.osplabs.com/
    Time Stamps
    00:07-01:33 Introduction
    01:34-04:14 Joshua Liu's Journey
    04:15-06:17 Challenges in Career Transition
    06:18-09:42 SeamlessMD Platform
    09:43-11:23 Remote Patient Monitoring 1.0 vs. 2.0
    11:24-13:05 Challenges of Traditional RPM
    13:06-19:06 Deviceless Solutions Impact
    19:07-22:09 Ensuring Accuracy and Reliability
    22:10-24:04 Closing Remarks

КОМЕНТАРІ •